«Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway». Nigerian Journal of Physiological Sciences, libk. 40, zenb. 2, 2025(e)ko abenduaren, or. 251-62, https://doi.org/10.54548/.